Speaker | |
Affiliation | Istituto Nanoscienze-CNR and Scuola Normale Superiore |
Date | 2022-11-17 |
Time | 11:00 |
Venue | |
Host | Fabio Taddei, Stefan Heun |
Glioblastoma multiforme (GBM) is a malignant form of brain tumor, which is characterized by extensive cellular and genetic heterogeneity, and poor prognosis. Calcium (Ca) signaling has been proposed to be directly involved in cancer proliferation and invasion, however there are no demonstrations in vivo of the correlation between GBM cell motility and calcium signaling. In light of this idea, we have produced a strain of mouse glioma cells (GL261) expressing a red fluorescent protein and a genetically encoded calcium sensor (GCaMP6s). Our findings demonstrate a heterogenous expression of Ca activity where most of the tumor volume is occupied by tightly packed spherical cells characterized by minimal motility and low Ca activity. Additionally, the dense tumoral area appear to have ensembles of cells displaying highly synchronized Ca waves propagating within cells and between distinct ensembles of cells based on their common activation. However, this core, is surrounded by sparse cells displaying a very polarized morphology, elevated migrational ability and active Ca signaling. We postulate that these regions represent the infiltrating component of the tumor. Next, in order to study GBM during development, we generated a spontaneous glioma model by overexpressing the active mutant of Ras (HRasV12) flanked by the consensus sequence for the piggyBac transposase. Using in utero electroporation technique, we transfected a small population of glia precursors with HRas, GCaMP6 and a red reporter. Two photon imaging demonstrated that, within 14 days from electroporation, the brain is gradually invaded by hypertrophic cells characterized by elevated motility and infiltrative potential. Similarly, to the GL261 model, the infiltration is organized in cell streams endowed by active Ca activity. Finally, we explored effects of a potential combination of drug (patented, in collaboration with SISSA, Trieste) for the treatment of GBM on our GL261 mouse model.
The seminar is realized in the framework of th funded projects:
Istituto Nanoscienze
Consiglio Nazionale delle Ricerche
PEC: protocollo.nano@pec.cnr.it
Partita IVA 02118311006
Piazza San Silvestro 12
56127 Pisa, Italy
phone +39 050 509418
fax +39 050 509550
Istituto Nanoscienze Consiglio Nazionale delle Ricerche
Piazza San Silvestro 12, I
56127 Pisa
phone +39 050 509525/418
fax +39 050 509550
via Campi 213/A, I
41125 Modena 7
phone +39 059 2055629
fax +39 059 2055651″
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |